Arcadia Biosciences (NASDAQ:RKDA) Stock Price Crosses Below 50 Day Moving Average – Here’s Why

Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.20 and traded as low as $0.8731. Arcadia Biosciences shares last traded at $0.9649, with a volume of 134,997 shares.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, May 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Arcadia Biosciences Stock Up 0.8%

The company has a market cap of $1.98 million, a PE ratio of -0.17 and a beta of 0.52. The business has a 50-day simple moving average of $1.20 and a 200-day simple moving average of $2.12.

Arcadia Biosciences (NASDAQ:RKDA) last announced its earnings results on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The firm had revenue of $1.10 million for the quarter, compared to analyst estimates of $1.60 million.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.